Lesson plan

DETQ

DETQ is an experimental drug which acts as a positive allosteric modulator of the dopamine D 1 receptor. It increases the D 1 receptor-mediated response to endogenous dopamine levels, and was developed as a potential treatment for Parkinson's disease.

Back to article

Article summary

DETQ is an experimental drug which acts as a positive allosteric modulator of the dopamine D 1 receptor. It increases the D 1 receptor-mediated response to endogenous dopamine levels, and was developed as a potential treatment for Parkinson's disease.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.